This inventor holds 1 USPTO granted patent. Top assignee: Bayer Pharma Aktiengesellschaft. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Susanne Parke: Innovator in Feminine Health
Introduction
Susanne Parke is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of feminine health through her innovative research and development. Her work focuses on enhancing women's well-being and addressing issues related to feminine libido.
Latest Patents
Susanne Parke holds a patent for her invention titled "Use of estradiol valerate or 17β-estradiol in combination with dienogest for oral therapy to maintain and/or increase feminine libido." This invention relates to the use of estradiol valerate or 17β-estradiol in combination with dienogest, aimed at improving feminine libido through a multistage or single-stage combination preparation for oral therapy. The total number of daily dose units in this combination amounts to 28 daily dose units.
Career Highlights
Throughout her career, Susanne has been associated with Bayer Pharma Aktiengesellschaft, where she has contributed to various projects aimed at improving women's health. Her dedication to research and innovation has positioned her as a key figure in her field.
Collaborations
Susanne Parke has collaborated with notable colleagues, including Holger Zimmermann and Susan Zeun. These partnerships have further enhanced her research and development efforts in feminine health.
Conclusion
Susanne Parke's innovative work in feminine health exemplifies her commitment to improving women's well-being. Her patent and collaborations reflect her significant contributions to the field, making her a noteworthy inventor in the industry.